The call, known as JAE PRE/MED, is aimed at graduates in Chemistry, Pharmacy, Biotechnology, or related fields who wish to specialize in modern drug discovery. The project focuses on integrating artificial intelligence, nanotechnology, and translational biology to optimize therapeutic candidates for conditions such as leukemia and multiple myeloma.
The selected researcher will join a collaborative environment using iterative design, synthesis, and experimental validation cycles. Training will include access to cutting-edge infrastructure for molecular characterization and nanomaterial analysis, under the supervision of experts in oncology and medicinal chemistry.
Requirements include a strong academic record and fluent English. The offer includes a gross annual salary of 32,565.71 euros, with a start date set before December 15, 2026. Successful candidates will receive scientific mentoring and opportunities to participate in conferences and training activities within the Chemistry Doctoral Program at the University of Seville.
